1. Home
  2. CAN vs BCYC Comparison

CAN vs BCYC Comparison

Compare CAN & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • BCYC
  • Stock Information
  • Founded
  • CAN 2013
  • BCYC 2009
  • Country
  • CAN Singapore
  • BCYC United Kingdom
  • Employees
  • CAN N/A
  • BCYC N/A
  • Industry
  • CAN Semiconductors
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAN Technology
  • BCYC Health Care
  • Exchange
  • CAN Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • CAN 511.2M
  • BCYC 449.5M
  • IPO Year
  • CAN 2019
  • BCYC 2019
  • Fundamental
  • Price
  • CAN $0.95
  • BCYC $6.60
  • Analyst Decision
  • CAN Strong Buy
  • BCYC Buy
  • Analyst Count
  • CAN 7
  • BCYC 11
  • Target Price
  • CAN $3.64
  • BCYC $20.73
  • AVG Volume (30 Days)
  • CAN 44.1M
  • BCYC 375.8K
  • Earning Date
  • CAN 11-18-2025
  • BCYC 10-30-2025
  • Dividend Yield
  • CAN N/A
  • BCYC N/A
  • EPS Growth
  • CAN N/A
  • BCYC N/A
  • EPS
  • CAN N/A
  • BCYC N/A
  • Revenue
  • CAN $422,228,000.00
  • BCYC $28,339,000.00
  • Revenue This Year
  • CAN $78.34
  • BCYC N/A
  • Revenue Next Year
  • CAN $50.58
  • BCYC N/A
  • P/E Ratio
  • CAN N/A
  • BCYC N/A
  • Revenue Growth
  • CAN 83.87
  • BCYC N/A
  • 52 Week Low
  • CAN $0.53
  • BCYC $6.03
  • 52 Week High
  • CAN $3.27
  • BCYC $21.60
  • Technical
  • Relative Strength Index (RSI)
  • CAN 41.21
  • BCYC 42.16
  • Support Level
  • CAN $0.86
  • BCYC $6.03
  • Resistance Level
  • CAN $1.11
  • BCYC $6.75
  • Average True Range (ATR)
  • CAN 0.13
  • BCYC 0.43
  • MACD
  • CAN -0.03
  • BCYC -0.02
  • Stochastic Oscillator
  • CAN 18.28
  • BCYC 57.16

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: